Hutch News

Hutch News

Stories tagged 'hutchinson institute for cancer outcomes research'

Big study finds no rise in death risk among women who took hormone therapy

A new twist to menopausal hormone replacement dilemma

Sept. 12, 2017 | Sabin Russell / Fred Hutch News Service

New follow-up research to a landmark study on menopausal hormone replacement therapy has found that women assigned to those drugs on the study had no higher risk of death than women who took a placebo.

View story >


New guidelines take aim at chemo-related nausea

Cancer patients ‘should not be vomiting with chemo anymore.’ Can someone please tell Hollywood?

Aug. 24, 2017 | By Diane Mapes / Fred Hutch News Service

Nausea and vomiting is a weird thing to … uh … bring up, writes cancer survivor Diane Mapes. But a lot of people don't seem to realize these common chemo side effects are now well controlled with anti-nausea drugs. New guidelines, co-written by Fred Hutch's Dr. Gary Lyman, break it all down.

View story >


Surviving cancer without going broke

HICOR’s Value in Cancer Care Summit tackles skyrocketing costs, financial toxicity, balancing cost with the right care and more

April 11, 2017 | By Diane Mapes / Fred Hutch News Service

About 200 patients, payers, providers and policymakers gathered with Fred Hutch researchers April 7 to discuss ways to bump value and bring down costs of cancer care. The day-long event marked the fourth Value in Cancer Care Summit, sponsored by the Hutchinson Institute for Cancer Outcomes Research.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Feb. 2, 2017

Novel gene therapy for sickle cell disease and related disorders on the horizon; immunotherapy trial in rare skin cancer named one of 2016’s major advances in clinical cancer research and care; Dr. Cara McDermott receives AcademyHealth new investigator award; and study documents sperm changes years after chemotherapy.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Nov. 21, 2016

Good News: Ceballos honored for public health research; ACS research awards to three Hutch scientists; ASH grant to physician-researcher Halpern; Paulovich facilitates Moonshot panel

View story >


Can Rx monopolies be tamed?

Why prescription drugs cost twice as much in U.S. versus other advanced nations ― and what might be done about it

Aug. 23, 2016 | By Bill Briggs / Fred Hutch News Service

A new study blames “government-protected monopolies” granted to drug makers for fueling the surge in prescription prices ― a trend that’s hitting American patients hardest of all.

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.